Bladder Cancer

1. Front Matter

   Pages i-xii

   PDF

2. The Epidemiology and Aetiology of Bladder Cancer

   • H. Rübben, W. Lutzeyer, D. M. A. Wallace

   Pages 1-21

3. The Histopathology of Bladder Cancer

   • J. N. Webb

   Pages 23-51

4. Immunological Aspects of Bladder Cancer

   • R. Ackermann

   Pages 53-76

5. Symptomatology

   • D. M. A. Wallace

   Pages 77-85

6. Diagnostic Procedures

   • M. C. Bishop

   Pages 87-115

7. Classification of Bladder Tumours

   • G. H. Jacobi, U. Engelmann, R. Hohenfellner

   Pages 117-139

8. Carcinoma In Situ

   • T. B. Hargreave

   Pages 141-159

9. The Treatment of Superficial Bladder Tumours

   • E. J. Zingg, D. M. A. Wallace

   Pages 161-187

10. The Treatment of Muscle Invasive Bladder Cancer

    • E. J. Zingg, P. N. Plowman, D. M. A. Wallace, P. C. Peters, J. P. Blandy

    Pages 189-234

11. Chemotherapy of Bladder Cancer

    • E. Messing, J. B. deKernion

    Pages 235-262

12. Palliative Treatment

    • K. H. Kurth

    Pages 263-297

13. Back Matter

    Pages 299-301

    PDF

Cancer of the bladder has a bad reputation: the combination of urinary problems and malignancy gives just cause for continuing concern. Not only is this common cancer a burden to the patient but, because of the need for regular follow-up, it creates a large workload on the urological services. It might be imagined that the bladder would give early warning signals of disease, and indeed it may do so; yet it can also be hesitant to reveal its severity. Thus there are many problems that create challenges in the diagnosis and management. Prevention is still the first goal of an oncologist, with early detection of early disease being the next best option. Early bladder cancer is amenable to several therapeutic approaches, but we have still to determine the best approach. The management of more advanced invasive bladder cancer all too often leads to disappointment, and we remain uncertain as to the optimum approach-surgery, radiotherapy, chemotherapy or some combination of these. Although none of these problems may be fully answered either now or in the near future, many people are working towards their solution, and the rate of progress needs to be documented from time to time. This volume aims to set the standard for the present state of our knowledge on bladder cancer. The editors, Professor Ernst Zingg and Mr'. Michael Wallace, have gathered together the best opinions on a wide range of topics relating to bladder cancer.

• cancer
• chemotherapy
• prevention
• radiotherapy
• surgery

• Department of Urology, University of Berne, Inselspital, Berne, Switzerland

  E. J. Zingg

• Department of Urology, Queen Elizabeth Medical Centre, Birmingham, England

  D. M. A. Wallace

Policies and ethics